Matinas BioPharma Holdings Message Board

What's the Strategy in the U.S. for Neovasc's Reducer?

3 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Matinas BioPharma Acquisition

5 months ago

You think Baker Brothers is happy about the offering Matinas just announced??

Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, Matinas BioPharma intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the …

Matinas $MTNB Study Versus Amarin $AMRN

5 months ago

There are so many AMRN investors who wish that guy was their CEO. Stock would be at $30 by now. Ha.

Matinas BioPharma Feasibility Evaluation with Genentech

6 months ago

I'm shocked the Matinas stock isn't up more on this news. This is the third feasibility evaluation with a biopharma for the Formulation of Compounds Utilizing LNC Delivery Platform.

“We are pleased to announce our third agreement with a large biopharmaceutical company during 2019 under which we have been asked to pair our LNC platform delivery technology with molecules which could potentially have a significant impact on disease burden. The interest shown by these companies in applying our plat…